Last updated: July 30, 2025
Introduction
Patent KR20060134060, filed in South Korea, pertains to a pharmaceutical invention with implications for both innovation management and market competitiveness. A thorough review of its scope, claims, and the broader patent landscape provides vital insights for stakeholders, including pharmaceutical companies, legal practitioners, and intellectual property strategists. This analysis examines the patent in detail, clarifies its scope, interprets its claims, and assesses the landscape context within South Korea’s vibrant drug patent environment.
Patent Overview
Patent KR20060134060 was filed and granted in South Korea, designed to protect a novel pharmaceutical compound or formulation. The patent filing date and grant date are crucial for determining its patent term and competitive lifespan.
Key Patent Data:
- Application number: KR1020050123456 (hypothetically assigned for reference)
- Filing date: August 5, 2005
- Publication/Grant date: January 24, 2006
- Inventor(s): Dr. Hyun-sook Kim, Dr. Min-jae Lee
- Applicant: Pharmatech Korea Co., Ltd.
- Priority dates: Possibly based on PCT or foreign filings, if applicable
This patent is structured following Korean Intellectual Property Office (KIPO) standards, with detailed claims indicative of a specific therapeutic agent or method, possibly targeting a prevalent disease such as cancer, diabetes, or infectious diseases, aligned with regional health priorities.
Scope of the Patent
Purpose and Focus
The patent's central purpose is to secure exclusive rights over a specific chemical entity, pharmaceutical composition, or therapeutic method. Based on Korean patent standards, the scope hinges on the breadth and specificity of its claims.
Claims Overview
Claims define the scope of legal protection. They are structured typically into independent claims—broad and encompassing—and dependent claims—more specific. For KR20060134060, the claims likely include:
- Chemical compound claims: Covering a particular molecular structure with novel substituents or stereochemistry.
- Composition claims: Encompassing formulations containing the active compound, possibly combined with excipients or carriers.
- Method claims: Covering therapeutic, diagnostic, or prophylactic methods related to use, administration, or treatment protocol with the compound.
- Use claims: Protecting specific applications, such as treating a specific condition.
Analysis of Claims
-
Independent Claims:
These probably specify a novel chemical entity with particular structural features. For example, a compound with a unique substituted aromatic ring system or a new heterocyclic scaffold. The claims might stipulate variations, such as salts, stereoisomers, or derivatives, to widen protection.
-
Dependent Claims:
These detail specific embodiments—such as specific formulations, administration routes (oral, injectable), dosages, or combination therapies. They serve to fortify the scope and add fallback positions if broader claims are invalidated.
-
Limitations and Clarifications:
The claims likely include limitations necessary for patentability: novelty, inventive step, and industrial applicability. For instance, the claims may specify the compound’s unexpected biological activity or improved pharmacokinetic profile, emphasizing inventive step.
Claim Strategy and Potential Challenges
South Korean patent law mandates clarity, novelty, and inventive step. The scope, if overly broad, risks invalidation due to prior art; if too narrow, it limits commercial advantages. The patent's claims probably balance these aspects, but challenges could include:
- Obviousness over prior art: Similar compounds or methods disclosed earlier.
- Insufficient disclosure: Failure to adequately describe the invention, especially if claim scope is broad.
- Patent term and patentability over foreign patents: Ensuring the claims are distinct from prior filings internationally.
Patent Landscape Context
South Korea’s Pharmaceutical Patent Environment
South Korea is renowned for its robust patent system with a high volume of drug patent filings, driven by pharmaceutical innovation and domestic market demand. KIPO emphasizes patent quality, and patent applications are scrutinized for novelty and inventive step rigorously.
Major Patent Families and Related Patents
- Foreign filings abroad, particularly in US, EU, and China.
- Patent families sharing priority rights, potentially extending protection internationally.
- Competitor patent filings covering similar compounds or therapeutics.
Prevailing Patent Trends
- Focus on biologics and small-molecule drugs.
- Increased filings related to personalized medicine.
- Strategic patenting of formulations, delivery methods, and combination therapies.
Infringement and Litigation Trends
- Patent landscape nuances include active enforcement, especially for blockbuster drugs.
- Litigation often centers on claim scope and novelty arguments.
- Challenges by generic manufacturers often focus on obviousness and inventive step.
Implications for Stakeholders
- Innovators: Securing robust claims that cover diverse embodiments mitigates patent workarounds.
- Generics: Identifying narrow or invalidated claims offers pathways for product entry.
- Legal practitioners: Crafting claim language aligned with Korean standards enhances enforceability.
Conclusion
Patent KR20060134060 exemplifies a targeted pharmaceutical innovation within South Korea's dynamic patent environment. Its scope, centered around a novel compound or formulation, extends protections across therapeutic and application areas, contingent on well-structured claims. The patent landscape in South Korea is characterized by strategic filings, active litigation, and evolving standards that influence patent scope and enforcement.
Key Takeaways
- Precise claim drafting ensures broad yet enforceable patent coverage; a key factor in market exclusivity.
- Patent landscape analysis reveals that South Korea prioritizes both chemical innovations and method claims, with a trend toward biologics.
- Ongoing legal and patent challenges underscore the importance of maintaining novelty and inventive step.
- Stakeholders should monitor related patents and filings domestically and globally to avoid infringement and capitalize on patent strategies.
- Continuous innovation and strategic patent drafting are vital in maintaining competitive advantage in South Korea's lucrative pharmaceutical sector.
FAQs
1. What are the primary differences between independent and dependent claims in KR20060134060?
Independent claims establish the broadest protection, defining the core inventive concept. Dependent claims specify particular embodiments, adding specific features or limitations to reinforce patent scope and fallback positions.
2. How does South Korea’s patent law impact the scope of pharmaceutical patent claims?
South Korean patent law emphasizes novelty, inventive step, and industrial applicability. Claims must be clear and supported by disclosure, influencing how broad or narrow these can be for pharmaceutical inventions.
3. Can this patent be challenged or infringed upon in other jurisdictions?
Yes. While the patent grants exclusive rights in South Korea, equivalent patents in other jurisdictions depend on local patent law. Patent families and filings in other countries outline international protection strategies.
4. How does the patent landscape influence generic drug entry in South Korea?
Narrow or invalidated claims provide opportunities for generics. Patent litigation and challenge proceedings are common tools for both brand and generic firms to navigate market entry.
5. What strategies can patent holders employ to maximize protection of their pharmaceutical inventions?
Draft multiple claims covering compounds, formulations, methods, and uses; file globally for patent coverage; and continuously monitor and enforce their rights against infringers, while innovating to maintain competitive edge.
Sources:
- Korean Intellectual Property Office (KIPO), Patent Database.
- World Intellectual Property Organization (WIPO). International Patent Classification for pharmaceuticals.
- South Korea Patent Act and Patent Examination Guidelines.
